The onset and extent of genomic instability in sporadic colorectal tumor progression

被引:284
作者
Stoler, DL
Chen, N
Basik, M
Kahlenberg, MS
Rodriguez-Bigas, MA
Petrelli, NJ
Anderson, GR [1 ]
机构
[1] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA
[2] Roswell Pk Canc Inst, Dept Expt Pathol, Buffalo, NY 14263 USA
[3] Roswell Pk Canc Inst, Dept Surg Oncol, Buffalo, NY 14263 USA
[4] Univ Montreal, Ctr Hosp, Montreal, PQ H2W 1T8, Canada
关键词
D O I
10.1073/pnas.96.26.15121
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Cancer cell genomes contain alterations beyond known etiologic events, but their total number has been unknown at even the order of magnitude level. By sampling colorectal premalignant polyp and carcinoma cell genomes through use of the technique inter-(simple sequence repeat) PCR, we have found genomic alterations to be considerably more abundant than expected, with the mean number of genomic events per carcinoma cell totaling approximately 11,000, Colonic polyps early in the tumor progression pathway showed similar numbers of events. These results indicate that, as with certain hereditary cancer syndromes, genomic destabilization is an early step in sporadic: tumor development. Together these results support the model of genomic instability being a cause rather than an effect of malignancy, facilitating vastly accelerated somatic cell evolution, with the observed orderly steps of the colon cancer progression pathway reflecting the consequences of natural selection.
引用
收藏
页码:15121 / 15126
页数:6
相关论文
共 40 条
[1]  
Alberts DS, 1998, CANCER J SCI AM, V4, P25
[2]   Assessment of genomic damage in colorectal cancer by DNA fingerprinting: Prognostic applications [J].
Arribas, R ;
Capella, G ;
Tortola, S ;
Masramon, L ;
Grizzle, WE ;
Perucho, M ;
Peinado, MA .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (10) :3230-3240
[3]  
BARRETT JC, 1990, UCLA SYM BI, V114, P97
[4]  
Basik M, 1997, GENE CHROMOSOME CANC, V18, P19, DOI 10.1002/(SICI)1098-2264(199701)18:1<19::AID-GCC3>3.3.CO
[5]  
2-2
[6]  
Becker J C, 1995, Recent Results Cancer Res, V139, P205
[7]  
Bentz M, 1998, GENE CHROMOSOME CANC, V21, P172, DOI 10.1002/(SICI)1098-2264(199802)21:2<172::AID-GCC14>3.3.CO
[8]  
2-T
[9]   Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance [J].
Boehm, T ;
Folkman, J ;
Browder, T ;
OReilly, MS .
NATURE, 1997, 390 (6658) :404-407
[10]  
Boland CR, 1998, CANCER RES, V58, P5248